Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival
- PMID: 19965613
- PMCID: PMC2853467
- DOI: 10.1194/jlr.M000398
Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival
Abstract
We recently reported that oxidized LDL (oxLDL) induces an oscillatory increase in intracellular calcium ([Ca(2+)](i)) levels in macrophages. Furthermore, we have shown that these [Ca(2+)](i) oscillations mediate oxLDL's ability to inhibit macrophage apoptosis in response to growth factor deprivation. However, the signal transduction pathways by which oxLDL induces [Ca(2+)](i) oscillations have not been elucidated. In this study, we show that these oscillations are mediated in part by intracellular mechanisms, as depleting extracellular Ca(2+) did not completely abolish the effect. Inhibiting sarco-endoplasmic reticulum ATPase (SERCA) completely blocked [Ca(2+)](i) oscillations, suggesting a role for Ca(2+) reuptake by the ER. The addition of oxLDL resulted in an almost immediate activation of sphingosine kinase (SK), which can increase sphingosine-1-phosphate (S1P) levels by phosphorylating sphingosine. Moreover, S1P was shown to be as effective as oxLDL in blocking macrophage apoptosis and producing [Ca(2+)](i) oscillations. This suggests that the mechanism in which oxLDL generates [Ca(2+)](i) oscillations may be 1) activation of SK, 2) SK-mediated increase in S1P levels, 3) S1P-mediated Ca(2+) release from intracellular stores, and 4) SERCA-mediated Ca(2+) reuptake back into the ER.
Figures









Similar articles
-
K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling.J Dermatol Sci. 2008 Aug;51(2):89-102. doi: 10.1016/j.jdermsci.2008.03.002. Epub 2008 Apr 16. J Dermatol Sci. 2008. PMID: 18420384
-
Sphingosine inhibits the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA) activity.Biochem Biophys Res Commun. 2016 Apr 29;473(2):572-7. doi: 10.1016/j.bbrc.2016.03.123. Epub 2016 Mar 28. Biochem Biophys Res Commun. 2016. PMID: 27033604
-
Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody.Br J Pharmacol. 2015 Jan;172(1):106-18. doi: 10.1111/bph.12897. Epub 2014 Nov 24. Br J Pharmacol. 2015. PMID: 25176316 Free PMC article.
-
Sarco-Endoplasmic Reticulum Calcium Release Model Based on Changes in the Luminal Calcium Content.Adv Exp Med Biol. 2020;1131:337-370. doi: 10.1007/978-3-030-12457-1_14. Adv Exp Med Biol. 2020. PMID: 31646517 Review.
-
Sphingosine 1-phosphate: a Ca2+ release mediator in the balance.Cell Calcium. 2002 Nov-Dec;32(5-6):335-41. doi: 10.1016/s0143416002001835. Cell Calcium. 2002. PMID: 12543093 Review.
Cited by
-
oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca2+ /K+ channel flow.J Cell Mol Med. 2017 May;21(5):929-940. doi: 10.1111/jcmm.13033. Epub 2016 Dec 20. J Cell Mol Med. 2017. PMID: 27995732 Free PMC article.
-
Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Chem Rev. 2011 Oct 12;111(10):6299-320. doi: 10.1021/cr200273u. Epub 2011 Sep 22. Chem Rev. 2011. PMID: 21939239 Free PMC article. Review. No abstract available.
-
The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes.Front Endocrinol (Lausanne). 2012 Jun 15;3:76. doi: 10.3389/fendo.2012.00076. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22715334 Free PMC article.
References
-
- Ross R. 1999. Atherosclerosis–an inflammatory disease. N. Engl. J. Med. 340: 115–126. - PubMed
-
- Libby P., Theroux P. 2005. Pathophysiology of coronary artery disease. Circulation. 111: 3481–3488. - PubMed
-
- Rosenfeld M. E., Ross R. 1990. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 10: 680–687. - PubMed
-
- Spagnoli L. G., Orlandi A., Santeusanio G. 1991. Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by colchicine show a macrophage phenotype. Atherosclerosis. 88: 87–92. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous